How should a patient with opioid use disorder take buprenorphine-naloxone (8-2 mg tablet) to achieve a daily dose of 12 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Take Buprenorphine-Naloxone 8-2 mg Tablets for a 12 mg Daily Dose

The patient should take one and a half tablets (1.5 tablets) of buprenorphine-naloxone 8-2 mg once daily to achieve the prescribed 12 mg dose.

Dosing Calculation and Administration

  • Each buprenorphine-naloxone 8-2 mg tablet contains 8 mg of buprenorphine (the active opioid component) and 2 mg of naloxone 1
  • To achieve 12 mg of buprenorphine daily: 12 mg ÷ 8 mg per tablet = 1.5 tablets 1
  • The patient should take 1.5 tablets as a single daily dose, administered sublingually (under the tongue) until completely dissolved 1, 2

Practical Administration Instructions

  • The tablets should be placed under the tongue and allowed to dissolve completely, which typically takes 5-10 minutes 1
  • Patients should not swallow, chew, or crush the tablets, as sublingual absorption is essential for proper bioavailability 1
  • To split a tablet for the half-tablet dose, the patient can use a pill cutter or break along the score line if present 1
  • The entire daily dose (1.5 tablets) should be taken at the same time each day to maintain stable blood levels 2

Clinical Context for Opioid Use Disorder Treatment

  • Buprenorphine-naloxone maintenance doses typically range from 8-24 mg daily, with 16 mg per day showing clear superiority over placebo 1
  • Fixed dosages of at least 7 mg per day are as effective as methadone for treatment retention and decreased opioid use 1
  • The 12 mg daily dose falls within the therapeutic range and should be continued as a scheduled daily medication, not on an as-needed basis 3, 2

Important Monitoring Considerations

  • Patients should be monitored for withdrawal symptoms, cravings, or continued opioid use, which may indicate the need for dose adjustment 1, 4
  • If withdrawal symptoms or cravings persist despite the 12 mg dose, the patient should be promptly evaluated for dose escalation up to 16-24 mg daily 4
  • Common adverse effects at this dose include constipation, headache, nausea, drowsiness, and sedation, which are generally well-tolerated 1, 5

References

Related Questions

What is the recommended dose range of Kadian (morphine sulfate) for opioid use disorder?
Can a Primary Care Physician (PCP) prescribe Suboxone (buprenorphine) for opioid use disorder?
What are the next steps in the treatment plan for Ropati's Substance Use Disorder (SUD), including risks and benefits?
What are the next steps for Ropati's treatment plan for Subacute Bacterial Endocarditis (SUB), including risks and benefits?
What is Direct Antiglobulin Test (DAT)?
What are the initial lab tests and management recommendations for a newly diagnosed hypertensive patient?
What is the treatment for a patient presenting with polymorphic ventricular tachycardia?
What is the differential diagnosis and management approach for an adult patient, possibly with underlying conditions such as diabetes, presenting with random body part involvement and triggers like hot showers, considering peripheral neuropathy (PN) and Complex Regional Pain Syndrome (CRPS)?
What treatment options are available for a patient with diabetes and peripheral neuropathy whose neuropathic pain worsens with hot showers?
What are the contraindications for using vancomycin, especially in patients with a history of hypersensitivity reactions, impaired renal function, or suspected/confirmed Enterococcus (E.) faecium infections?
Is chemoprophylaxis (use of medications to prevent disease, such as azithromycin) necessary for individuals in close contact with a pertussis (whooping cough) patient, particularly those at high risk of severe disease, including young children, pregnant women, and individuals with underlying medical conditions like immunodeficiency or chronic respiratory disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.